OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Moderna Inc/  US60770K1079  /

NASDAQ
5/21/2024  9:17:13 PM Chg. +1.2300 Volume Bid5/21/2024 Ask5/21/2024 Market Capitalization Dividend Y. P/E Ratio
142.2400USD +0.87% 2.32 mill.
Turnover: 226.28 mill.		 142.1800Bid Size: 200 142.2400Ask Size: 200 54.37 bill.USD - -
TeleTrader 5/20 Dow slumps 195 points at closing bell after corporate news
GlobeNewswire 5/16 CytomX Therapeutics Announces New Employment Inducement Grants
TeleTrader 5/13 Wall Street closes mixed ahead of key inflation data
GlobeNewswire 5/12 TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire 5/8 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/8 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
TeleTrader 5/2 US surges at close as traders weigh Fed remarks
TeleTrader 5/2 Moderna surges 9% as Q1 revenue beat expectations
GlobeNewswire 5/2 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
TeleTrader 5/2 Moderna sees $167M in Q1 revenue, beats forecasts
TeleTrader 5/2 US higher premarket after Fed's decision
GlobeNewswire 5/1 Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire 5/1 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
TeleTrader 4/24 Moderna, OpenAI partner on mRNA medicine advancement
TeleTrader 4/9 US markets close mostly higher ahead of inflation report
GlobeNewswire 4/4 Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
TeleTrader 3/28 US closes mixed amid data
TeleTrader 3/26 Wall Street closes lower after economic data
GlobeNewswire 3/21 Immatics Announces Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 3/11 CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update
GlobeNewswire 3/4 CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
GlobeNewswire 2/29 Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
GlobeNewswire 2/27 CytomX Therapeutics to Present at Upcoming March Investor Conferences
TeleTrader 2/23 Asia-Pacific mostly up on US markets gains
TeleTrader 2/22 Nasdaq closes with 3% boost led by Nvidia rally